Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jian Jian Luan"'
Autor:
P. Biron, Ariane Boumendil, Kirsty Thomson, J.Y. Cahn, Augustin Ferrant, Hervé Tilly, Michael Pfreundschuh, Anna Sureda, Peter Dreger, Philippe Colombat, Jian Jian Luan, John G. Gribben, Inas El-Najjar, Andrew P. Haynes, Gordon Cook, Silvia Montoto, Catherine Cordonnier, Jean-Paul Vernant, R. Bouabdallah, Herve Finel, M. Mohty
Publikováno v:
Annals of Oncology. 25:2224-2229
Background The aim of this study was to investigate the impact of the high-dose regimen on the outcome of patients with follicular lymphoma (FL) having had autologous stem-cell transplantation (ASCT) in a recent time period. Patients Between 1995 and
Publikováno v:
The Journal of Experimental Medicine
Nonobese diabetic (NOD) mice develop spontaneous autoimmune diabetes that results from the destruction of insulin secreting β cells by diabetogenic T cells. The time and location of the encounter of autoantigen(s) by naive autoreactive T cells in no
Autor:
Stefano Guidi, Anna Sureda, Roelof Willemze, Barbara Sarina, Ladislav Jebavy, Edward Kanfer, Simona Sica, Alessandro Pulsoni, David Sibon, Jian Jian Luan, Carmen Canals, Carmen Martínez, Alberto Bosi, Peter Dreger, Reyes Arranz, D. Karakasis, C.A. De Souza, Emilio Paolo Alessandrino, John A. Snowden, Rosi Oneto, Andrzej Hellmann, Luca Castagna, Marek Trneny, Noel-Jean Milpied
BACKGROUND High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395a285532dc059d4e92dc48f55753a2
http://hdl.handle.net/11573/580982
http://hdl.handle.net/11573/580982
Autor:
Peter Dreger, P. Biron, Jian Jian Luan, Carmen Canals, Augustin Ferrant, Esa Jantunen, Charles Crawley, H. Tilly, Michel Attal, P. W. Wijermans, K Thomson, Noel-Jean Milpied, Agnes Buzyn, Bernard Rio, Anton Schattenberg, Anna Sureda
Publikováno v:
Annals of Oncology, 23, 166-71
Annals of Oncology, Vol. 23, no. 1, p. 166-171 (2012)
Annals of Oncology, 23, 1, pp. 166-71
Annals of Oncology, Vol. 23, no. 1, p. 166-171 (2012)
Annals of Oncology, 23, 1, pp. 166-71
Background: Limited experience is available on the feasibility and efficacy of autologous stem-cell transplantation (ASCT) in patients with mantle cell lymphoma (MCL) beyond 65 years. Design and methods: We analysed 712 patients with MCL treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d2f88e7101a60df9f9588a03ad1113
http://hdl.handle.net/2066/110339
http://hdl.handle.net/2066/110339
Publikováno v:
European Journal of Immunology. 24:380-384
The non-obese diabetic (NOD) mouse strain provides a remarkable model for investigating the mechanisms of autoimmunity. Independent genetic analyses of this model have previously shown that chromosome 1-linked loci were involved in the control of per
Autor:
Jian Jian Luan, Jean Paul Vernant, Kirsty Thomson, Agnès Buzyn, Harry C. Schouten, Jean Pierre Jouet, Roel J.W. van Kampen, Gert J. Ossenkoppele, Carmen Canals, Arnon Nagler, Sébastien Maury, Marc Boogaerts, Noel Milpied, Anna Sureda
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Clinical Oncology, 29(10), 1342-1348. American Society of Clinical Oncology
van Kampen, R J W, Canals, C, Schouten, H C, Nagler, A, Thomson, K J, Vernant, J P, Buzyn, A, Boogaerts, M A, Luan, J J, Maury, S, Milpied, N J, Jouet, J P, Ossenkoppele, G J & Sureda, A 2011, ' Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry ', Journal of Clinical Oncology, vol. 29, no. 10, pp. 1342-1348 . https://doi.org/10.1200/JCO.2010.30.2596
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Clinical Oncology, 29(10), 1342-1348. American Society of Clinical Oncology
van Kampen, R J W, Canals, C, Schouten, H C, Nagler, A, Thomson, K J, Vernant, J P, Buzyn, A, Boogaerts, M A, Luan, J J, Maury, S, Milpied, N J, Jouet, J P, Ossenkoppele, G J & Sureda, A 2011, ' Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry ', Journal of Clinical Oncology, vol. 29, no. 10, pp. 1342-1348 . https://doi.org/10.1200/JCO.2010.30.2596
Purpose To analyze the outcome, including nonrelapse mortality (NRM), relapse rate (RR), progression-free survival (PFS), and overall survival (OS), of patients with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) relapsed after an autologous ste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719ea57602b860ada5f79e599582dc7a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12138
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12138
Publikováno v:
Diabetes. 42:1823-1828
The nonobese diabetic mouse in a model of spontaneous development of autoimmune type I diabetes. The disease can be induced in young, irradiated recipients by injecting splenic T-cells from diabetic donors. The adoptive transfer of diabetes requires
Publikováno v:
Diabetes. 42:134-140
It is well established that the NOD mouse develops T-cell-dependent autoimmune type I diabetes that is abolished by neonatal Tx and enhanced by Tx at weaning. In a previous study, we demonstrated that the NOD thymus displays various abnormalities in
Autor:
Ilya, Chumakov, Marta, Blumenfeld, Oxana, Guerassimenko, Laurent, Cavarec, Marta, Palicio, Hadi, Abderrahim, Lydie, Bougueleret, Caroline, Barry, Hiroaki, Tanaka, Philippe, La Rosa, Anne, Puech, Nadia, Tahri, Annick, Cohen-Akenine, Sylvain, Delabrosse, Sébastien, Lissarrague, Françoise-Pascaline, Picard, Karelle, Maurice, Laurent, Essioux, Philippe, Millasseau, Pascale, Grel, Virginie, Debailleul, Anne-Marie, Simon, Dominique, Caterina, Isabelle, Dufaure, Kattayoun, Malekzadeh, Maria, Belova, Jian-Jian, Luan, Michel, Bouillot, Jean-Luc, Sambucy, Gwenael, Primas, Martial, Saumier, Nadia, Boubkiri, Sandrine, Martin-Saumier, Myriam, Nasroune, Hélène, Peixoto, Arnaud, Delaye, Virginie, Pinchot, Mariam, Bastucci, Sophie, Guillou, Magali, Chevillon, Ricardo, Sainz-Fuertes, Said, Meguenni, Joan, Aurich-Costa, Dorra, Cherif, Anne, Gimalac, Cornelia, Van Duijn, Denis, Gauvreau, Gail, Ouellette, Isabel, Fortier, John, Raelson, Tatiana, Sherbatich, Nadejda, Riazanskaia, Evgeny, Rogaev, Peter, Raeymaekers, Jeroen, Aerssens, Frank, Konings, Walter, Luyten, Fabio, Macciardi, Pak C, Sham, Richard E, Straub, Daniel R, Weinberger, Nadine, Cohen, Daniel, Cohen, Gail, Ouelette, John, Realson
Publikováno v:
Proceedings of the National Academy of Sciences of the U.S.A., 99, 13675-13680. National Academy of Sciences
A map of 191 single-nucleotide polymorphism (SNPs) was built across a 5-Mb segment from chromosome 13q34 that has been genetically linked to schizophrenia. DNA from 213 schizophrenic patients and 241 normal individuals from Canada were genotyped with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83667f3c76d9cca850cd3d8b7c5233ee
https://pure.eur.nl/en/publications/0848e3a4-4a47-4286-aca4-f79574228a30
https://pure.eur.nl/en/publications/0848e3a4-4a47-4286-aca4-f79574228a30
Autor:
Michal Sieniawski, Urs Schanz, Ariane Boumendil, Kim Orchard, Marc Renaud, Didier Blaise, Kirsty Thomson, Peter Dreger, Paneesha Shankara, Norbert Schmitz, Catherine Thieblemond, Anna Sureda, Jian Jian Luan, Charles Crawley, Patrice Chevalier, Martin Gramatzki
Publikováno v:
Blood. 122:4636-4636
The occurrence of late events [i.e. secondary malignancies (SM)] after therapy is of special relevance in patients with Hodgkin«s lymphoma (HL) as the median age of this population is quite low and first line therapy is curative in a high proportion